Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms responsible for therapy resistance of acute myelogenous leukemia (AML).

International journal of clinical pharmacology and therapeutics - 1 Feb 1998

Köhler T, Eller J, Leiblein S, Lassner D, Helbig W, Remke H, Wagner O

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to ATP-Binding Cassette Transporters

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple

Share to Germany

Share to Monocytes

Share to Multidrug Resistance-Associated Proteins

Share to Proto-Oncogene Proteins c-bcl-2

Source

Identifiers

PMID: 9520156

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanisms responsible for therapy resistance of acute myelogenous leukemia (AML).PMID 9520156Read ↗

Mechanisms of drug resistance in AML.Semantic proximity Read ↗

Mechanisms of drug resistance in acute myeloid leukemiaSemantic proximity Read ↗

Mechanisms, treatment strategies and predictive biomarkers of drug resistance in acute myeloid leukemia.Semantic proximity Read ↗

Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?Semantic proximity Read ↗

Non-genetic mechanisms of drug resistance in acute leukemiasSemantic proximity Read ↗

Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemiaSemantic proximity Read ↗

Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia.Semantic proximity Read ↗

Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An UpdateSemantic proximity Read ↗

The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML.Semantic proximity Read ↗

An arms‐race against resistance: leukemic stem cells and lineage plasticitySemantic proximity Read ↗

Resistance in chronic myeloid leukemia: definitions and novel therapeutic agentsSemantic proximity Read ↗

A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.